Victor Rossiev

Statistics

Publications

Citations

154

H-Index

Active since

2014

Affiliations

University Medical Center Hamburg-Eppendorf(Current)

Princess Margaret Cancer Centre

Victor Rossiev is an author at University Medical Center Hamburg-Eppendorf specializing in pharmacotherapy, oncology pharmacotherapy, and lenalidomide therapy.

Publications per year

2014–2022

Publications

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia

Carlo Gambacorti‐Passerini, Jörge E. Cortes, Jeff H. Lipton et al. · American Journal of Hematology · 2014 · 107 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12

1–2 of 2